STEAP2
Assets acting on this target.
- Class
- Antibody-drug conjugate (TOP1i)
By indication
Related mechanisms
STEAP2 drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| AZD0516 | AstraZeneca | antibody-drug conjugate | Phase 1/2 | Phase 1/2 in Prostate Cancer |
| AZD0754 | AstraZeneca | cell therapy (CAR-T) | Phase 1/2 | Phase 1/2 in Prostate Cancer |
| AZD2284 | AstraZeneca | radioconjugate (actinium-225) | Phase 1 | Phase 1 in Prostate Cancer |